Zydus Wellness, a leading consumer health and wellness company in India, saw its share price soar 19% to ₹528.10 on the Bombay Stock Exchange (BSE), nearing its record high of ₹530.55 reached on September 19, 2025. This surge occurred amid heavy trading volumes, with 23.55 million shares changing hands, representing 8% of the company’s total equity. The jump in share price follows Zydus Wellness's impressive Q3 performance, where it reported a 113.7% year-on-year increase in net sales, reaching ₹963.3 crore. The company's EBITDA also saw a substantial rise of 312.2% year-on-year, attributed to the post-acquisition performance of its newly acquired business. Motilal Oswal Financial Services has recommended a 'Buy' rating on the stock, with a target price of ₹575, anticipating an 8% organic revenue growth in the upcoming March 2026 quarter. The overall fast-moving consumer goods (FMCG) market is expected to expand significantly, projected to reach ₹53.4 trillion (approximately $615.87 billion) by 2027, reflecting a compound annual growth rate (CAGR) of 22.76% from 2021. Despite ongoing geopolitical tensions affecting international operations, rural demand remains robust, and urban demand shows signs of improvement.